An Unusual Case of Multiple Sclerosis Presenting with Skew Deviation Following COVID Vaccination

Anupama Janardhanan¹ and Shashikant Shetty^2,

¹Paediatric Ophthalmology and strabismus Fellow, Department of Paediatric Ophthalmology and Adult Strabismus, Aravind Eye Hospital, Madurai, India

²Head of the Department, Department of Paediatric Ophthalmology and Adult Strabismus, Aravind Eye Hospital, Madurai, India

Cite this paper:
Anupama Janardhanan and Shashikant Shetty. An Unusual Case of Multiple Sclerosis Presenting with Skew Deviation Following COVID Vaccination. Neuro-Ophthalmology & Visual Neuroscience. 2022; 7(1):1-4. doi: 10.12691/novn-7-1-1

Abstract

Ocular tilt reaction is an uncommon phenomenon. It is usually misdiagnosed as superior oblique palsy. One of the rare oculomotor presentations of multiple sclerosis is ocular tilt reaction. Large number of people get affected by multiple sclerosis every year. Prompt diagnosis and timely intervention helps in long term rehabilitation and prevents irreversible sequele. We report a case of a young girl with no prior history of any co morbidity, presented with double vision and was diagnosed with ocular tilt reaction. The only attributable history was of receiving COVID vaccine. On further evaluation and literature review the case was differentiated from an adverse reaction of COVID vaccination. A diagnosis of multiple sclerosis was determined that enabled early initiation of appropriate systemic therapy for her. In our knowledge, this becomes the first case report that describes, an ocular tilt reaction as a manifestation of multiple sclerosis following COVID vaccination.

Keywords:
skew deviation ocular tilt reaction COVID vaccine multiple sclerosis vertical deviation

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Nerrant E, Tilikete C. Ocular Motor Manifestations of Multiple Sclerosis. Journal of Neuro-Ophthalmology, 37(3): 332-40, Sep 201.
[2]	Servillo G, Renard D, Taieb G. Bedside Tested Ocular Motor Disorders in Multiple Sclerosis Patients. Multiple Sclerosis International, 1-4, Apr 2014.
[3]	Cerqueira JJ, Compston DAS, Geraldes RR, et al. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis. J Neurol Neurosurg Psychiatry , 1-7, Apr 2018.
[4]	Brodsky MC, Donahue SP, Vaphiades M. Skew deviation revisited. Survey of Ophthalmology [Internet]. 1; 51(2): 105-28. Mar 2006.
[5]	Westheimer G, Blair SM. The ocular tilt reaction--a brainstem oculomotor routine. Investigative Ophthalmology 14(11): 833-9. Nov 1975.
[6]	Kushner BJ. Errors in the Three-step Test in the Diagnosis of Vertical Strabismus. Ophthalmology. 96(1): 127 32. Jan 1982.
[7]	Donahue SP, Lavin PJ, Mohney B. Skew deviation and inferior oblique palsy. American Journal of Ophthalmology 132(5):751-6. Nov 2001.
[8]	Wong AMF. Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy. Journal of American Association for Pediatric Ophthalmology and Strabismus. 14(1): 61-7. Feb 2010.
[9]	Fujimori J, Miyazawa K, Nakashima I. Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. Journal of Neuroimmunology 15; 361: 577755. Dec 2021.
[10]	Maniscalco GT, Manzo V, Di Battista ME. Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report. Frontiers in Neurology, 12:721502. Aug 2021.
[11]	Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 397(10269). Dec 2020.
[12]	Mailand MT, Frederiksen JL: Vaccines and multiple sclerosis: a systematic review, J Neurol., 264: 1035-50. Jun 2017.
[13]	Farez MF, Correale J, Armstrong MJ, et al.: Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology, 93: 584-94, Sep 2019.
[14]	Langer-Gould A, Qian L, Tartof SY, et al.: Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol, 71:1506-13, Dec 2014.
[15]	Achiron A, Dolev M, Menascu S, Zohar D-N, Dreyer-Alster S, Miron S, et al. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Multiple Sclerosis Journal. 15; 27(6): 864-70. Apr 2021.